AQR Capital Management - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 64 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q1 2018$1,443,000
+144.2%
48,809
+225.3%
0.00%
+100.0%
Q4 2017$591,000
+79.6%
15,005
+24.5%
0.00%
Q3 2017$329,000
+38.8%
12,054
+18.4%
0.00%
Q2 2017$237,00010,1810.00%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Zeal Asset Management Ltd 2,339,885$93,421,00021.31%
UG Investment Advisers Ltd. 33,155$1,302,0002.52%
Pinz Capital Management, LP 159,400$6,260,0001.88%
Capital International Sarl 547,743$21,510,0001.86%
Capital International, Inc./CA/ 4,391,684$172,461,0001.54%
AIA Group Ltd 437,118$17,380,0001.20%
York Capital Management Global Advisors, LLC 182,297$7,159,0000.80%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 68,000$2,671,0000.70%
E Fund Management (Hong Kong) Co., Ltd. 18,579$730,0000.46%
M&G INVESTMENT MANAGEMENT LTD 4,512,562$175,990,0000.44%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders